Care of the human immunodeficiency virus-infected menopausal woman

American Journal of Obstetrics and Gynecology

Volumn 207, Issue 2, 2012, Pages 87-93

  Cejtin, Helen Elizabeth ^a,b  

^a Jr Hospital of Cook County   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

bone mineral density; cognitive impairment; human immunodeficiency virus infection; menopause; vasomotor symptoms

Indexed keywords

VITAMIN D;

ALCOHOL ABSTINENCE; BONE DENSITY; CANCER SCREENING; COGNITION; COGNITIVE DEFECT; COMORBIDITY; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENOPAUSE; NUTRITION; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; SMOKING CESSATION; VITAMIN INTAKE; WEIGHT BEARING; WEIGHT GAIN; WELLBEING; WOMEN'S HEALTH;

AGING; ANTI-RETROVIRAL AGENTS; BONE DENSITY; BONE DISEASES, METABOLIC; COGNITION DISORDERS; FEMALE; HIPPOCAMPUS; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MASS SCREENING; MENOPAUSE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; UTERINE CERVICAL NEOPLASMS;

EID: 84864408358     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.12.031     Document Type: Review

References (114)

1. N. Lohse, A.B. Hansen, J. Gerstoft, N. Obel Improved survival in HIV-infected persons: consequences and perspectives J Antimicrob Chemother 60 2007 461 463
2. Centers for Disease Control and Prevention HIV surveillance report, 2008 Vol. 20 June 2010 www.cdc.gov/hiv/surveillance/resources/reports/2008report Accessed April 17, 2011
3. Centers for Disease Control and Prevention HIV/AIDS surveillance report, 2000. Vol. 12, no. 2 www.cdc.gov/hiv/surveillance/resources/reports/2000report Accessed Nov. 21, 2011
4. B.M. Branson, H.H. Handsfield, M.A. Lampe Centers for Disease Control and Prevention Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings MMWR 55 2006 1 17
5. S.T. Lindau, M.A. Schumm, E.O. Laumann A study of sexuality and health among older adults in the United States N Engl J Med 357 2007 762 774
6. A.B. Jena, D.P. Goldman, A. Kamdar, D.N. Lakdawalla, Y. Lu Sexually transmitted infections among users of erectile dysfunction drugs: analysis of claims data Ann Intern Med 153 2010 1 7
7. L. Mingjia, R. Short How estrogen or progesterone might change a woman's susceptibility to HIV-1 infection Aust N Z J Obstet Gynaecol 42 2002 472 475
8. S.M. Smith, B.G. Baskin, P.A. Marx Estrogen protects against vaginal transmission of simian immunodeficiency virus J Infect Dis 182 2000 708 715
9. World Health Organization (WHO) Research on the menopause in the 1990's. Report of a World Health Organization Scientific Group. WHO technical report series, no. 866 Geneva, Switzerland 1994
10. D.J. Brambilla, S.M. McKinlay A prospective study of factors affecting age at menopause J Clin Epidemiol 42 1989 1031 1039
11. S. Sherman Natural history of menopause studies and related efforts at the National Institute on Aging, NIH H.P.G. Schneider, F. Naftolin, Climacteric medicine: where do we go? 1st ed. 2005 Taylor and Francis London 16 26
12. J.T. Bromberger, K.A. Matthews, L.H. Kuller, R.R. Wing, E.N. Meilahn, P. Plantinga Prospective study of the determinants of age at menopause Am J Epidemiol 145 1997 124 133
13. F. Parazzini Progetto Menopausa Italia Study Group Determinants of age at menopause in women attending menopause clinics in Italy Maturitas 56 2007 280 287
14. G.S. Cooper, D.P. Sandler, M. Bohlig Active and passive smoking and the occurrence of natural menopause Epidemiology 10 1999 771 773
15. D.J. Torgerson, A. Avenell, I.T. Russell, D.M. Reid Factors associated with onset of menopause in women aged 45-49 Maturitas 19 1994 83 92
16. E.B. Gold, J. Bromberger, S. Crawford Factors associated with age at natural menopause in a multiethnic sample of midlife women Am J Epidemiol 153 2001 865 874
17. K.D. Chirgwin, J. Feldman, O. Muneyyirci-Delale, S. Landesman, H. Minkoff Menstrual function in human immunodeficiency virus-infected women without acquired immunodeficiency syndrome J Acquir Immune Defic Syndr 12 1996 489 494
18. S. Grinspoon, C. Corcoran, K. Miller Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting J Clin Endocrinol Metab 82 1997 1332 1337
19. S.D. Harlow, P. Schuman, M. Cohen Effect of HIV infection on menstrual cycle length J Acquir Immune Defic Syndr 24 2000 68 75
20. T.V. Ellerbrock, T.C. Wright, T.J. Bush, P. Dole, K. Brudney, M.A. Chiasson Characteristics of menstruation in women infected with human immunodeficiency virus Obstet Gynecol 87 1996 1030 1034
21. L.S. Massad, C. Evans, H. Minkoff Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women J Womens Health (Larchmt) 15 2006 591 598
22. S.D. Harlow, M. Cohen, S.E. Ohmit Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virus Am J Obstet Gynecol 188 2003 881 886
23. R.A. Clark, K. Mulligan, E. Stamenovic Frequency of anovulation and early menopause among women enrolled in selected adult AIDS clinical trials group studies J Infect Dis 184 2001 1325 1327
24. L.E. Fantry, M. Zhan, G.H. Taylor, A.M. Sill, J.A. Flaws Age of menopause and menopausal symptoms in HIV-infected women AIDS Patient Care STDS 19 2005 703 711
25. E.E. Shoenbaum, D. Hartel, Y. Lo HIV infection, drug use, and onset of natural menopause Clin Infect Dis 41 2005 1517 1524
26. H.E. Cejtin, A. Kalinowski, P. Bacchetti Effects of human immunodeficiency virus on protracted amenorrhea and ovarian dysfunction Obstet Gynecol 108 2006 1423 1431
27. D.B. Seifer, E.T. Golub, G. Lambert-Messerlian Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women Fertil Steril 88 2007 1645 1652
28. J. Cofrancesco Jr, N. Shah, K.G. Ghanem The effects of illicit drug use and HIV infection on sex hormone levels in women Gynecol Endocrinol 22 2006 244 251
29. D.A. Potter, A. Moreno, M.F. Luther Effects of follicular-phase cocaine administration on menstrual and ovarian cyclicity in rhesus monkeys Am J Obstet Gynecol 178 1998 118 125
30. G.A. Greendale, E.B. Gold Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy? Am J Med 118 2005 148 154
31. D. Grady Clinical practice: management of menopausal symptoms N Engl J Med 355 2006 2338 2347
32. N.E. Avis, P.A. Kaufert, M. Lock, S.M. McKinlay, K. Vass The evolution of menopausal symptoms Baillieres Clin Endocrinol Metab 7 1993 17 32
33. E.B. Gold, B. Sternfeld, J.L. Kelsey Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age Am J Epidemiol 152 2000 463 473
34. S.A. Miller, N. Santoro, Y. Lo Menopause symptoms in HIV-infected and drug-using women Menopause 12 2005 348 356
35. C.E. Ferreira, A.M. Pinto-Neto, D.M. Conde, L. Costa-Paiva, S.S. Morais, J. Magalhaes Menopause symptoms in women infected with HIV: prevalence and associated factors Gynecol Endocrinol 23 2007 198 205
36. R.A. Clark, S.E. Cohn, C. Jarek Perimenopausal symptomatology among HIV-infected women at least 40 years of age J Acquir Immune Defic Syndr 23 2000 99 100
37. T.M. Johnson, H.W. Cohen, A.A. Howard Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women Menopause 15 2008 551 557
38. B. Sommer, N. Avis, P. Meyer Attitudes toward menopause and aging across ethnic/racial groups Psychosom Med 61 1999 868 875
39. D. Hartel, Y. Lo, C. Bauer Attitudes toward menopause in HIV-infected and at-risk women Clin Interv Aging 3 2008 561 566
40. R.A. Clark, T. Bessinger Clinical manifestations and predictors of survival among older women infected with HIV J Acquir Immune Defic Syndr 15 1997 341 345
41. US Department of Health and Human Services Health Resources and Services Administration A guide to the clinical care of women with HIV/AIDS, 2005 ed http://hab.hrsa.gov/publications/womencare05 Accessed April 17, 2011
42. S.Y. El-Ibiary, J.M. Cocohoba Effects of antiretrovirals on the pharmacokinetics of hormonal contraception Eur J Contracept Reprod Health Care 13 2008 123 132
43. J.R. Anderson Approach to the patient J.R. Anderson, A guide to the clinical care of women with HIV 2005 Health Resources and Services Administration Rockville, MD 35 46
44. L. Mosca, P. Collins, D. Herrington Hormone replacement therapy and cardiovascular disease Circulation 101 2001 499
45. S. Cu-Uvin, J.W. Hogam, D. Warren Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women; HIV Epidemiology Research Study Group Clin Infect Dis 29 1999 1145 1150
46. B.L. Anderson, S. Cu-Uvin Determinants of HIV shedding in the lower genital tract of women Curr Infect Dis Rep 10 2008 505 511
47. K.A. Workowski, S.M. Berman Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines, 2006 MMWR Recomm Rep 55 2006 1 94
48. European Study Group Comparison of female to male and male to female transmission of HIV in 563 stable copies; European Study Group on Heterosexual Transmission of HIV BMJ 304 1992 809 813
49. P. Aaby, K. Arlyoshi, M. Buckner Age of wife as a major determinant of male-to-female transmission of HIV-2 infection: a community study from rural West Africa AIDS 10 1996 1585 1590
50. C. Rollenhagen, S.N. Asin Enhanced HIV-1 replication in ex vivo ectocervical tissues from postmenopausal women correlates with increased inflammatory processes Mucosal Immunol 4 2011 671 681
51. + T-cells in healthy post-menopausal women JAIDS 2011 Nov 11 [Epub ahead of print]
52. American College of Obstetricians and Gynecologistis Cervical cytology screening. ACOG practice bulletin no. 109, Dec. 2009 Obstet Gynecol 114 2009 1409 1420
53. J.E. Kaplan, C. Benson, K.H. Holmes Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America Guidelines for prevention and treatment of opportunistic Infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America MMWR Recomm Rep 58 2009 1 207
54. S.J. Goldie, K.A. Freedberg, M.C. Weinstein, T.C. Wright, K.M. Kuntz Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus Am J Med 111 2001 140 149
55. T. Darragh, B. Winkler Anal cancer and cervical cancer screening: key differences Cytopathology 119 2011 5 19
56. B. Stone, D. Dockrell, C. Bowman, E. McCloskey HIV and bone disease Arch Biochem Biophys 503 2010 66 77
57. T.T. Brown, R.B. Qaqish Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review AIDS 20 2006 2165 2174
58. D.L. Jacobson, D. Spiegelman, T.K. Know, I.B. Wilson Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study J Acquir Immune Defic Syndr 49 2008 298 308
59. K. Mondy, W.G. Powderly, S.A. Claxton Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection J Acquir Immune Defic Syndr 38 2005 426 431
60. J.A. Kanis, F. Borgstrom, C. De Laet Assessment of fracture risk Osteoporosis Int 16 2005 581 589
61. E.M. Haney, S.J. Warden, M.M. Bliziotes Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention, and management? Bone 46 2010 13 17
62. M. Pedrazzoni, L. Vescovi, M. Maninetti Effects of chronic heroin abuse on bone and mineral metabolism Acta Endocrinol 129 1993 42 45
63. V. Lo Re III, G. Guaraldi, M.B. Leonard Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men AIDS 23 2009 2191 2198
64. T.T. Brown, M.D. Ruppe, R. Kassner Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia J Clin Endocrinol Metab 89 2004 1200 1206
65. M. Rodriguez, S. Gunawardene, G.K. Robbins High frequency of vitamin D deficiency in ambulatory HIV-positive patients AIDS Res Human Retroviruses 25 2009 9 14
66. Guaraldi G, Orlando G, Squillace N, et al. Prevalence of secondary causes of osteoporosis among HIV-infected individuals. In: Program and abstracts of the 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, San Francisco, CA, Sept. 24-26, 2006.
67. C.N. Dao, P. Patel, E.T. Overton Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN) Investigators Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population Clin Infect Dis 52 2011 396 405
68. K. Mondy, K. Yarasheski, W.J. Powderly Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals Clin Infect Dis 36 2003 482 490
69. A. Fausto, M. Bongiovanni, P. Cicconi Potential predictive factors of osteoporosis in HIV-positive subjects Bone 38 2006 893 897
70. C. Cazanave, M. Dupon, V. Lavignolle-Aurillac Reduced bone mineral density in HIV-infected patients: prevalence and associated factors AIDS 22 2008 395 402
71. J.M. Fakruddin, J. Laurence HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity Arch Virol 150 2005 67 78
72. D. Gibellini, E. De Crignis, C. Ponti HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNF-alpha activation J Med Virol 80 2008 1507 1514
73. S.E. Dolan, J.S. Huang, K.M. Killilea, M.P. Sullivan, N. Aliabadi, S. Grinspoon Reduced bone density in HIV-infected women AIDS 18 2004 475 483
74. B. Grund, G. Peng, C.L. Gibert INSIGHT SMART Body Composition Substudy Group Continuous antiretroviral therapy decreases bone mineral density AIDS 23 2009 1519 1529
75. T.T. Brown, G.A. McComsey, M.S. King, R.B. Qaqish, B.M. Bernstein, B.A. daSilva Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen J Acquir Immune Defic Syndr 51 2009 554 561
76. P.W. Mallon, J. Miller, D.A. Cooper, A. Carr Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy AIDS 17 2003 971 979
77. J.E. Gallant, S. Staszewski, A.I. Pozniak Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naïve patients: a 3-year randomized trial JAMA 292 2004 191 201
78. D.A. Cooper, M. Bloch, A. Humphries et al. Simplification with fixed-dose tenofovir-emtricitabine or abacavir-lamivudine in adults with suppressed HIV replication (the Steal Study): a randomized, open-label, 96-week, non-inferiority trial (abstract 576) Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada Feb. 8-11, 2009
79. C.A. Fux, A. Rauch, M. Simcock Swiss HIV Cohort Study Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study Antivir Ther 13 2008 1077 1082
80. M. Cozzolino, M. Vidal, M.V. Arcidiacono, P. Tebas, K.E. Yarasheski, A.S. Dusso HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D AIDS 17 2003 513 520
81. J.H. Arnsten, R. Freeman, A. Howard, M. Floris-Moore, Y. Lo, R. Klein Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection AIDS 21 2007 617 623
82. J.A. Womack, J.L. Goulet, S. Gilbert Increased risk of fragility fractures among HIV-infected compared to uninfected male veterans PLoS One 6 2011 e17217
83. V.A. Triant, T.T. Brown, H. Lee, S.K. Grinspoon Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large US healthcare system J Clin Endocrinol Metab 93 2008 3499 3504
84. G.A. McComsey, M.A. Kendall, P. Tebas Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV AIDS 21 2007 2473 2482
85. M.T. Yin, D.J. McMahon, D.C. Ferris Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women J Clin Endocrinol Metab 95 2010 620 629
86. J. Huang, L. Meixner, S. Fernandez, J.A. McCutchan A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis AIDS 23 2009 51 57
87. S.E. Dolan Looby, M. Collins, H. Lee, S. Grinspoon Effects of long-term testosterone administration in HIV-infected women: a randomized, placebo-controlled trial AIDS 23 2009 951 959
88. Prevention and Management of Non-infectious Co-morbidities in HIV The European AIDS Clinical Society Guidelines, 2009 www.europeanaidsclinical- society.org/guidelines.asp Accessed April 17, 2011
89. World Health Organization Fracture Risk Assessment Tool University of Sheffield, United Kingdom http://www.shef.ac.uk/FRAX Accessed March 19, 2011
90. G.A. McComsey, P. Tebas, E. Shane Bone disease in HIV infection: a practical review and recommendations for HIV care providers Clin Infect Dis 51 2010 937 946
91. J.A. Aberg, J.E. Kaplan, H. Libman HIV Medicine Association of the Infectious Disease Society of America Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America Clin Infect Dis 49 2009 651 681
92. C.H. Hinkin, S.A. Castellon, J.H. Atkinson, K. Goodkin Neuropsychiatric aspects of HIV infection among older adults J Clin Epidemiol 54 2001 S44 S52
93. L. Malaspina, S.P. Woods, D.J. Moore HIV Neurobehavioral Research Programs (HNRP) Group Successful cognitive aging in persons living with HIV infection J Neurovirol 17 2011 110 119
94. A.A. Gorman, J.M. Foley, M.L. Ettenhofer, C.H. Hinkin, W.G. van Gorp Functional consequences of HIV-associated neuropsychological impairment Neuropsychol Rev 19 2009 186 203
95. M.L. Ettenhofer, C.H. Hinkin, S.A. Castellon Aging, neurocognition, and medication adherence in HIV infection Am J Geriatr Psychiatry 17 2009 281 290
96. D.J. Hardy, D.E. Vance The neuropsychology of HIV/AIDS in older adults Neuropsychol Rev 19 2009 263 272
97. M.R. Basso, R.A. Bornstein Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12 months J Clin Exp Neuropsychol 22 2000 208 218
98. P.L. Fazeli, J.C. Marceaux, D.E. Vance, L. Slater, C.A. Long Predictors of cognition in adults with HIV: implications for nursing practice and research J Neurosci Nurs 43 2011 36 50
99. K. Lin, M.J. Taylor, R. Heaton CHARTER Group Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals J Clin Exp Neuropsychol 33 2011 326 334
100. N.D. Pukay-Martin, S.A. Cristiani, R. Saveanu, R.A. Bornstein The relationship between stressful life-events and cognitive function in HIV-infected men J Neuropsychiatry Clin Neurosci 15 2003 436 441
101. E.M. Martin-Thormeyer, R.H. Paul Drug abuse and hepatitis C infection as comorbid features of HIV-associated neurocognitive disorder: neurocognitive and neuroimaging features Neuropsychol Rev 19 2009 215 231
102. J.L. Richardson, E.M. Martin, N. Jiminez Neuropsychological functioning in a cohort of HIV-infected women: importance of antiretroviral therapy J Int Neuropsychol Soc 8 2002 781 793
103. J.L. Richardson, M. Mowicki, K. Danley Neuropsychological functioning in a cohort of HIV- and HCV-infected women AIDS 19 2005 1659 1667
104. N. Sacktor, R.H. Lyles, R. Skolasky Multicenter AIDS Cohort Study HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998 Neurology 56 2001 257 260
105. B.J. Brew Evidence for change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex AIDS 18 Suppl 2004 S75 S78
106. R.A. Fox-Tierney, J.R. Ickovics, C.L. Cerreta, K.A. Ethier Potential sex differences remain understudied: a case study of the inclusion of women in HIV/AIDS-related neuropsychological research Rev Gen Psychol 3 1999 44 54
107. F.H. Bouwman, R.L. Ckolasky, D. Hes Variable progression of HIV-associated dementia Neurology 50 1998 1814 1820
108. R.S. Darvasula, E.N. Miller, H.F. Myers, G.E. Wyatt Predictors of neuropsychological performance in HIV positive women J Clin Exp Neuropsychol 23 2001 149 163
109. E.B. Gold, B. Sternfeld, J.L. Kelsey Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age Am J Epidemiol 152 2000 463 473
110. J.L. Fuh, S.J. Wang, S.J. Lee, S.R. Lu, K.D. Juang A longitudinal study of cognition change during early menopausal transition in a rural community Maturitas 53 2005 447 453
111. P.M. Meyer, L.H. Powell, R.S. Wilson A population-based longitudinal study of cognitive functioning in the menopausal transition Neurology 61 2003 801 806
112. P.M. Maki, L.L. Drogos, L.H. Rubin, S. Banuvar, L.P. Shulman, S.E. Geller Objective hot flashes are negatively related to verbal memory performance in midlife women Menopause 15 2008 848 856
113. E. Sundermann, L.H. Rubin, E. Martin, M. Cohen, K. Weber, P.M. Maki Relationships among menopausal symptoms, sex steroid hormones and cognitive dysfunction in women with HIV Paper presented at: the 38th annual meeting of the International Society of Psychoneuroendocrinology Madison, WI Aug. 19, 2007
114. P.M. Maki, E. Martin-Thormeyer HIV, cognition and women Neuropsychol Rev 19 2009 204 214